Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Partnership in the capacities and on the dates indicated. for Abraxis

Send us Feedback

Abraxis BioScience (ABII)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

ABII » Topics » Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Partnership in the capacities and on the dates indicated.

This excerpt taken from the ABII 10-K filed Mar 12, 2010.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Partnership in the capacities and on the dates indicated.


Signature	Title	Date

/s/ PATRICK SOON-SHIONG, M.D. Patrick Soon-Shiong, M.D.	Executive Chairman	March 12, 2010

/s/ BRUCE J. WENDEL Bruce J. Wendel	Vice Chairman, and Chief Executive Officer	March 12, 2010

/s/ MITCHELL K. FOGELMAN Mitchell K. Fogelman	Senior Vice President of Finance (Principal Financial and Accounting Officer)	March 12, 2010

/s/ KIRK K. CALHOUN Kirk K. Calhoun	Director	March 12, 2010

/s/ DAVID S. CHEN, PH.D. David S. Chen Ph.D.	Director	March 12, 2010

/s/ STEPHEN D. NIMER, M.D. Stephen D. Nimer, M.D.	Director	March 12, 2010

/s/ LEONARD S. SHAPIRO Leonard S. Shapiro	Director	March 12, 2010

/s/ MICHAEL SITRICK Michael Sitrick	Director	March 12, 2010

This excerpt taken from the ABII 10-K filed Mar 6, 2009.


Signature	Title	Date

/s/ PATRICK SOON-SHIONG, M.D. Patrick Soon-Shiong, M.D.	Chairman of the Board of Directors and Chief Executive Officer (Principal Executive Officer)	March 6, 2009

/s/ DAVID O’TOOLE David O’Toole	Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)	March 6, 2009

/s/ KIRK K. CALHOUN Kirk K. Calhoun	Director	March 6, 2009

/s/ DAVID S. CHEN, PH.D. David S. Chen Ph.D.	Director	March 6, 2009

/s/ STEPHEN D. NIMER, M.D. Stephen D. Nimer, M.D.	Director	March 6, 2009

/s/ LEONARD S. SHAPIRO Leonard S. Shapiro	Director	March 6, 2009

This excerpt taken from the ABII 10-K filed Mar 31, 2008.


Signature	Title	Date

/s/ PATRICK SOON-SHIONG, M.D. Patrick Soon-Shiong, M.D.	Chairman of the Board of Directors and Chief Executive Officer (Principal Executive Officer)	March 31, 2008

/s/ LISA GOPALAKRISHNAN Lisa Gopalakrishnan	Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)	March 31, 2008

/s/ KIRK K. CALHOUN Kirk K. Calhoun	Director	March 31, 2008

/s/ DAVID S. CHEN, PH.D. David S. Chen Ph.D.	Director	March 31, 2008

/s/ STEPHEN D. NIMER, M.D. Stephen D. Nimer, M.D.	Director	March 31, 2008

/s/ LEONARD S. SHAPIRO Leonard S. Shapiro	Director	March 31, 2008

EXCERPTS ON THIS PAGE:

10-K	Mar 12, 2010

10-K	Mar 6, 2009

10-K	Mar 31, 2008

"Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Partnership in the capacities and on the dates indicated." elsewhere:

Anesiva (ANSV)
CuraGen (CRGN)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Abraxis BioScience (ABII)

ABII » Topics » Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Partnership in the capacities and on the dates indicated.

Table of Contents

Table of Contents

Table of Contents

EXCERPTS ON THIS PAGE:

RELATED TOPICS for ABII:

"Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Partnership in the capacities and on the dates indicated." elsewhere: